Evidence map›Paper›PMID 33306336›Full record

ArticleTurkish journal of medical sciences2021

Vitamin D receptor polymorphisms and bone health after kidney transplantation

Berfu Korucu, Ajlan Tükün, Özant Helvacı, Hasan Yeter, Sevim Gönen, Galip Güz, Turgay Arınsoy

Open access · bronzeAbstract read
In one paragraph

Article in Turkish journal of medical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Berfu KorucuDepartment of Nephrology, Faculty of Medicine, Gazi University, Ankara, TurkeyORCID 0000-0002-0597-5822
Ajlan TükünDepartment of Medical Genetics, Düzen Laboratories Group, İstanbul, TurkeyORCID 0000-0001-7445-0918
Özant HelvacıDepartment of Nephrology, Faculty of Medicine, Gazi University, Ankara, TurkeyORCID 0000-0002-1382-2439
Hasan YeterDepartment of Nephrology, Faculty of Medicine, Gazi University, Ankara, TurkeyORCID 0000-0002-5787-1048
Sevim GönenHLA Tissue Typing Laboratory, Faculty of Medicine, Gazi University, Ankara, TurkeyORCID 0000-0002-2059-6193
Galip GüzDepartment of Nephrology, Faculty of Medicine, Gazi University, Ankara, TurkeyORCID 0000-0002-9146-2133
Turgay ArınsoyDepartment of Nephrology, Faculty of Medicine, Gazi University, Ankara, TurkeyORCID 0000-0001-7268-055X
Gazi University · TRTurkish Society of Hematology · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/aim: Bone disease is one of the most prominent complications after kidney transplantation. Bone diseases include osteoporosis, persistent secondary hyperparathyroidism, and avascular necrosis (AVN). We investigated the relationship between the polymorphisms of the vitamin D receptor (VDR) gene and bone diseases occurring after kidney transplantation. Materials and methods: The study consists of 234 kidney allograft recipients with a minimum follow-up of five years after kidney transplantation. Patients with glomerular filtration rates less than 30 mL/min/1.73m2, a history of parathyroidectomy, bisphosphonate use pre- or post-transplantation, and cinacalcet use posttransplantation excluded. We evaluated associations between the polymorphisms of the VDR gene (BsmI, TaqI, ApaI, FokI, and Cdx2), the first-year bone mineral density (BMD) scores, persistent secondary hyperparathyroidism, and AVN. Results: Patients with low BMD scores were significantly younger (P = 0.03) and had higher intact parathormone (iPTH) levels (P = 0.03). Cdx2 TT genotype significantly increases the risk of low BMD scores (OR: 3.34, P = 0.04). Higher phosphate levels were protective against abnormal BMD scores (OR: 0.53; P = 0.03). Patients with persistent hyperparathyroidism had significantly longer dialysis vintage and higher pretransplantation iPTH levels (P = 0.02 and P < 0.001, respectively). Cdx2, CT/TT, and ApaI CA/AA genotypes significantly increase the risk of persistent hyperparathyroidism (OR: 6.81, P < 0.001, OR: 23.32, P < 0.001, OR:4.01, P = 0.02, and OR: 6.30, P = 0.01; respectively). BsmI CT/TT genotypes were found to increase AVN risk with an HR of 3.48 (P = 0.03). Higher hemoglobin levels were also found to decrease AVN risk with an HR of 0.76 (P = 0.05). Conclusion: Certain VDR gene polymorphisms are associated with a higher risk for bone diseases after kidney transplantation.

Indexed as

OsteonecrosisAdultBone DensityFemaleGenotypeHumansHyperparathyroidism, SecondaryKidney TransplantationMaleMiddle AgedParathyroid HormonePolymorphism, GeneticReceptors, CalcitriolParathyroid HormoneReceptors, Calcitriolavascular necrosisKidney transplantationosteoporosispersistent hyperparathyroidismVDR polymorphisms

Identifiers

PMID33306336
PMCPMC8203162
OpenAlexW3112788180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.